Sign in Pull a receipt

ADAG

Adagene Inc.

Healthcare · Biotechnology

$157.19 sample

-1.62 (-1.02%) 1D

Market cap

$244.3B

Price as of

2026-10-24

Latest filing

8-K

Alerts

8

Price$157.19 -0.32% 3M daily closessample

169.95156.10

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 14INSInsider sell: Director
Oct 08INSInsider sell: EVP, Operations
Sep 29INSInsider sell: General Counsel
Sep 18INSInsider sell: General Counsel
Sep 10INSInsider sell: Chief Financial Officer
Sep 03INSInsider buy: 10% owner
Aug 25INSInsider sell: EVP, Operations
Aug 18INSInsider buy: 10% owner

Sign up to see the real ADAG record →

Company facts

SEC EDGAR registration

Name: Adagene Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in ADAG

sample

Insiders: 33 insider transactions over 90 days, net selling, $834.6M
Congress: 2 members traded over 90 days
Institutions · 13F: 9 funds hold $2.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.4B +14.1% y/y

Q4 2024Q3 2026

Inventory$7.7B +15.8% y/y

Q4 2024Q3 2026

Accounts receivable$5.7B +14.6% y/y

Q4 2024Q3 2026

Total debt$14.4B +11.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $54.7B +3.3% 3M
Sample peer B: $78.5B +15.4% 3M
Sample peer C: $197.7B +7.6% 3M
Sample peer D: $154.4B +15.0% 3M
Sample peer E: $183.1B -3.9% 3M